|
Company Name | Product name | Phase of development* | HSV vaccine type | Mode of action† |
|
Micro-Antigen Technologies, LLC | “Asymptomatic” Lipopeptide | PC | Peptide-based Self-adjuvanting | P&T |
AlphaVax, Inc. | HSV Vaccine ALPHAVAX | PC | Alphavirus vector | P&T |
Genocea Biosciences | HSV2 Vaccine GENOCEA | PC | Undisclosed | P&T |
Henderson Morley plc | L-particles | PC | VLP | P |
Henderson Morley plc | PREPS (previral DNA replication enveloped particles) | PC | VLP | P |
JN International Medical Corporation | Genital Herpes Vaccine JN INTERNATIONAL | PC | Subunit | P |
Juvaris Biotherapeutics, Inc | JVRS100 with Herpes Simplex Virus-2 Antigens | PC | Subunit gB, gDt, gH/gL JVRS-100 adjuvant | P |
Mymetics Corporation | Herpes Simplex Virus Vaccine MYMETICS | PC | VLP | P |
Sanofi-aventis | ACAM529 | PC | Replication-defective virus | P&T |
BioVex Inc. | ImmunoVEX HSV2 Vaccine | I | Live-attenuated virus | P |
Pfizer Inc. | Genital Herpes DNA Vaccine PFIZER INC | I | DNA via PMED | T |
AuRx, Inc. | Theraherb | III | Live-attenuated virus | T |
GlaxoSmithKline plc | Simplirix | F | Subunit gD2 SBAS4 adjuvant | P |
Acuvax Ltd (formerly Avantogen Limited) | HSV 2 ACUVAX | D | Live-attenuated virus GPI-0100 adjuvant | T |
Antigenics Inc. | AG702 | D | Subunit gB2 Human HSP-70 adjuvant | T |
Antigenics Inc. | AG707 | D | Subunit 32 peptides Human HSP-70 adjuvant | T |
BioVex Inc. | ImmunoVEX HSV2/HPV Vaccine | D | HSV-2/HPV Combined | P&T |
Celldex Therapeutics, Inc. | Dl5-29 Vaccine CELLDEX | D | Live, replication-impaired virus | T |
Celtic Pharma Management L.P. | DISC Pro | D | DISC | P |
Novartis AG | Genital Herpes DNA Vaccine NOVARTIS | D | DNA | T |
Celtic Pharma Management L.P. | TAHSV | F | DISC | T |
Eli Lilly&Co. | Resiquimod ELI LILLY | F | TLR agonist | T |
GenVec Inc. | Herpes Simplex Virus Type 2 Vaccine GENVEC | NA | Adenovirus vector | P&T |
Profectus bioSciences, Inc. | Herpes Simplex Virus Vaccine PROFECTUS BIOSCIENCES | NA | DNA with recombinant VSV boost | T |
Vical Inc. | Herpes Simplex Virus Type 2 Vaccine VICAL | NA | DNA Vaxfectin adjuvant | T |
|